Bibliometric perspectives on inflammatory and immunological research in pediatric asthma

Danqing Hu1,2, Ling Mei3, Dongyang An4

  • 1The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.

Insights

Pediatric asthma research has surged, with the U.S. leading. Key findings show allergic and type 2 inflammation as drivers, with inhaled corticosteroids and biologics as effective treatments for childhood asthma.

Area of Science:

  • Pediatric respiratory medicine
  • Immunology
  • Allergy

Background:

  • Pediatric bronchial asthma is a widespread chronic inflammatory respiratory condition affecting children globally.
  • Limited bibliometric analyses exist for its inflammatory and immunological aspects.
  • This study addresses this gap by analyzing research trends.

Purpose of the Study:

  • To provide an overview of pediatric asthma research.
  • To identify key focus areas and emerging trends in its inflammatory and immunological aspects.
  • To analyze publication trends, influential institutions, authors, and keywords.

Main Methods:

  • Bibliometric analysis of 911 papers from Web of Science (2000-2024).
  • Utilized CiteSpace, VOSviewer, and Bibliometrix for collaborative network and co-citation analysis.
  • Identified publication growth, leading contributors, and keyword clusters.

Main Results:

  • Research output increased significantly since 2006, with the U.S. as the leading publisher.
  • Anne M. Fitzpatrick identified as the leading author; "Allergy, Asthma & Immunology Reviews" as the most influential journal.
  • Key research hotspots include "efficacy" and "allergic rhinitis," with allergic and type 2 inflammation as primary mechanisms.

Conclusions:

  • Pediatric asthma research shows substantial growth, driven by U.S. contributions.
  • Allergic airway inflammation and type 2 inflammation are central pathogenic mechanisms.
  • Inhaled corticosteroids and biologics are effective treatments, underscoring the need for continued global research.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
231
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
244
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
156
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K